These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 11247328)

  • 1. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
    Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW
    Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-sectional evaluation of YKL-40 serum concentrations in patients with systemic sclerosis. Relationship with clinical and serological aspects of disease.
    La Montagna G; D'Angelo S; Valentini G
    J Rheumatol; 2003 Oct; 30(10):2147-51. PubMed ID: 14528508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of soluble TNF alpha receptor type I and the severity of systemic sclerosis.
    Majewski S; Wojas-Pelc A; Malejczyk M; Szymanska E; Jablonska S
    Acta Derm Venereol; 1999 May; 79(3):207-10. PubMed ID: 10384918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis.
    Gonzalez-Lopez L; Rocha-Muñoz AD; Olivas-Flores EM; Garcia-Gonzalez A; Peguero-Gómez AR; Flores-Navarro J; Villa-Manzano AI; Zavaleta-Muñiz SA; Salazar-Paramo M; Mejía M; Juárez-Contreras P; Vazquez-Del Mercado M; Cardona-Muñoz EG; Trujillo-Hernández B; Nava-Zavala AH; Gamez-Nava JI
    Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble serum interleukin 2 receptors in patients with systemic sclerosis.
    Steen VD; Engel EE; Charley MR; Medsger TA
    J Rheumatol; 1996 Apr; 23(4):646-9. PubMed ID: 8730120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivity of prolactin in systemic sclerosis.
    La Montagna G; Meli R; Criscuolo T; D'Angelo S; Valentini G
    Clin Exp Rheumatol; 2004; 22(2):145-50. PubMed ID: 15083880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term therapy with plasma exchange in systemic sclerosis: effects on laboratory markers reflecting disease activity.
    Cozzi F; Marson P; Rosada M; De Silvestro G; Bullo A; Punzi L; Todesco S
    Transfus Apher Sci; 2001 Aug; 25(1):25-31. PubMed ID: 11791759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels.
    Polisson RP; Gilkeson GS; Pyun EH; Pisetsky DS; Smith EA; Simon LS
    J Rheumatol; 1996 Apr; 23(4):654-8. PubMed ID: 8730122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum aminoterminal propeptide of type III procollagen in systemic sclerosis. A follow-up--investigations in subclasses and during therapy.
    Heickendorff L; Parvez A; Bjerring P; Halkier-Sørensen L; Zachariae H
    Acta Derm Venereol; 1991; 71(3):185-8. PubMed ID: 1678217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis.
    Lammi L; Kinnula V; Lähde S; Risteli J; Pääkkö P; Lakari E; Ryhänen L
    Eur Respir J; 1997 Dec; 10(12):2725-30. PubMed ID: 9493651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of amino terminal propeptide of type III procollagen are an unfavourable predictor of survival in systemic sclerosis.
    Nagy Z; Czirják L
    Clin Exp Rheumatol; 2005; 23(2):165-72. PubMed ID: 15895885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Wenyang Huazhuo Tongluo Recipe on Peripheral Blood Thl7/Treg Cell Balance in Systemic Sclerosis Patients].
    Bian H; Yuan M; Gao Zhong-ming ; Bi XD; Han L; Hu JL; Mao BY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Aug; 35(8):975-80. PubMed ID: 26485914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Soluble receptors of cytokines in sera of patients with systemic sclerosis--clinical correlation].
    Lis AD; Brzezińska-Wcisło LA
    Wiad Lek; 2003; 56(11-12):532-6. PubMed ID: 15058159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma).
    Scheja A; Akesson A; Geborek P; Wildt M; Wollheim CB; Wollheim FA; Vischer UM
    Arthritis Res; 2001; 3(3):178-82. PubMed ID: 11299058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis.
    Scheja A; Akesson A; Hørslev-Petersen K
    Scand J Rheumatol; 1992; 21(1):5-9. PubMed ID: 1570489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma endothelin and the aminoterminal propeptide of type III procollagen (PIIINP) in systemic sclerosis.
    Zachariae H; Heickendorff L; Bjerring P; Halkier-Sørensen L; Søndergaard K
    Acta Derm Venereol; 1994 Sep; 74(5):368-70. PubMed ID: 7817674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
    Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis.
    Brkic Z; van Bon L; Cossu M; van Helden-Meeuwsen CG; Vonk MC; Knaapen H; van den Berg W; Dalm VA; Van Daele PL; Severino A; Maria NI; Guillen S; Dik WA; Beretta L; Versnel MA; Radstake T
    Ann Rheum Dis; 2016 Aug; 75(8):1567-73. PubMed ID: 26371289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of circulating intercellular adhesion molecule-1 in patients with systemic sclerosis.
    Kiener H; Graninger W; Machold K; Aringer M; Graninger WB
    Clin Exp Rheumatol; 1994; 12(5):483-7. PubMed ID: 7842528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum aminoterminal propeptide of type III procollagen in progressive systemic sclerosis and localized scleroderma.
    Zachariae H; Halkier-Sørensen L; Heickendorff L
    Acta Derm Venereol; 1989; 69(1):66-70. PubMed ID: 2563612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.